01531nam 2200397Ia 450 991069880250332120090608142609.0(CKB)5470000002397846(OCoLC)374687851(EXLCZ)99547000000239784620090608d1998 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] supplemental testing and the notification of consignees of donor test results for antibody to hepatitis C virus (anti-HCV)Rockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[1998]8 pages digital, PDF fileTitle from PDF title page (viewed on June 8, 2009)."March 1998".Includes bibliographical references (page 8).Guidance for industry BloodExaminationGovernment policyUnited StatesImmunoglobulinsUnited StatesHepatitis C virusGovernment policyUnited StatesBloodExaminationGovernment policyImmunoglobulinsHepatitis C virusGovernment policyCenter for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698802503321Guidance for industry3434577UNINA